RxDoctor Payments Data

Deanna Fulbright

Family Medicine · Saint Joseph, MINPI 1548671837

Payments from drug & device makers

$3,542in general payments, 2019–2025

Across 21 payments — averaging $168.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tosoh Bioscience, Inc.$3K
  • Novo Nordisk$527
  • Abbott$68
  • Lilly USA, LLC$56
  • AbbVie$35
  • GSK$14

What the payments were for

  • Food & beverage$70020%
  • Gifts$2,84280%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tosoh Bioscience, Inc.2$2,842
Novo Nordisk15$527
Abbott1$68
Lilly USA, LLC1$56
AbbVie1$35
GSK1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,542 in reported general payments places this provider in the 85th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$74,477
Medicare patients
218
Services billed
1,584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$50,043
OzempicSemaglutide18$28,425
FarxigaDapagliflozin Propanediol22$25,923
TrulicityDulaglutide12$19,804
MounjaroTirzepatide12$18,542
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$12,756
Tresiba Flextouch U-100Insulin Degludec11$10,180
JardianceEmpagliflozin13$8,315
Atorvastatin Calcium241$2,931
Levothyroxine Sodium174$2,068
Duloxetine Hcl50$1,591
Amlodipine Besylate204$1,466
Omeprazole87$1,305
Lisinopril141$1,304
Ipratropium Bromide16$1,258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$56$38,34524 claims
Novo NordiskOzempic$527$28,42518 claims
GSKTrelegy Ellipta$14$12,75612 claims
AbbVieSynthroid$35$1,08516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saint Joseph

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →